JCIC Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.4K | Hold |
235
| – | – | 0.01% | 98 |
|
|
2026
Q1 | $20.4K | Hold |
235
| – | – | 0.01% | 98 |
|
|
2025
Q4 | $22.6K | Hold |
235
| – | – | 0.01% | 90 |
|
|
2025
Q3 | $22.4K | Buy |
+235
| New | +$21.6K | 0.01% | 91 |
|
|
2025
Q1 | $21.1K | Hold |
235
| – | – | 0.01% | 92 |
|
|
2024
Q4 | $18.8K | Hold |
235
| – | – | 0.01% | 86 |
|
|
2024
Q3 | $21.2K | Hold |
235
| – | – | 0.01% | 83 |
|
|
2024
Q2 | $18.5K | Hold |
235
| – | – | 0.01% | 85 |
|
|
2024
Q1 | $20.5K | Hold |
235
| – | – | 0.01% | 86 |
|
|
2023
Q4 | $19.4K | Hold |
235
| – | – | 0.01% | 88 |
|
|
2023
Q3 | $18.4K | Hold |
235
| – | – | 0.01% | 90 |
|
|
2023
Q2 | $20.7K | Hold |
235
| – | – | 0.01% | 89 |
|
|
2023
Q1 | $18.9K | Hold |
235
| – | – | 0.01% | 90 |
|
|
2022
Q4 | $18K | Hold |
235
| – | – | 0.01% | 92 |
|
|
2022
Q3 | $21K | Hold |
235
| – | – | 0.01% | 88 |
|
|
2022
Q2 | $21K | Hold |
235
| – | – | 0.01% | 79 |
|
|
2022
Q1 | $26K | Hold |
235
| – | – | 0.01% | 94 |
|
|
2021
Q4 | $24K | Hold |
235
| – | – | 0.01% | 94 |
|
|
2021
Q3 | $29K | Hold |
235
| – | – | 0.01% | 84 |
|
|
2021
Q2 | $36K | Hold |
235
| – | – | 0.01% | 87 |
|
|
2021
Q1 | $28K | Hold |
235
| – | – | 0.01% | 87 |
|
|
2020
Q4 | $28K | Buy |
235
+181
| +335% | +$19.9K | 0.01% | 85 |
|
|
2020
Q3 | $6K | Hold |
54
| – | – | ﹤0.01% | 94 |
|
|
2020
Q2 | $5K | Hold |
54
| – | – | ﹤0.01% | 85 |
|
|
2020
Q1 | $5K | Sell |
54
-107
| -66% | -$11.4K | ﹤0.01% | 89 |
|
|
2019
Q4 | $18K | Buy |
161
+123
| +324% | +$13.5K | 0.01% | 86 |
|
|
2019
Q3 | $4K | Hold |
38
| – | – | ﹤0.01% | 112 |
|
|
2019
Q2 | $4K | Sell |
38
-169
| -82% | -$15.4K | ﹤0.01% | 109 |
|
|
2019
Q1 | $19K | Buy |
207
+169
| +445% | +$15.1K | 0.01% | 82 |
|
|
2018
Q4 | $3K | Hold |
38
| – | – | ﹤0.01% | 113 |
|
|
2018
Q3 | $4K | Hold |
38
| – | – | ﹤0.01% | 114 |
|
|
2018
Q2 | $3K | Hold |
38
| – | – | ﹤0.01% | 112 |
|
|
2018
Q1 | $3K | Buy |
+38
| New | +$3.13K | ﹤0.01% | 111 |
|
|
2017
Q3 | – | Sell |
-97,243
| Closed | -$8.63M | – | 67 |
|
|
2017
Q2 | $8.63M | Sell |
97,243
-2,170
| -2% | -$183K | 2.97% | 14 |
|
|
2017
Q1 | $8.01M | Sell |
99,413
-14,320
| -13% | -$1.12M | 2.81% | 17 |
|
|
2016
Q4 | $8.1M | Sell |
113,733
-20,295
| -15% | -$1.59M | 2.74% | 20 |
|
|
2016
Q3 | $11.6M | Sell |
134,028
-11,855
| -8% | -$1.03M | 3.64% | 12 |
|
|
2016
Q2 | $12.7M | Sell |
145,883
-17,815
| -11% | -$1.44M | 3.77% | 12 |
|
|
2016
Q1 | $12.3M | Sell |
163,698
-42,525
| -21% | -$3.2M | 3.4% | 15 |
|
|
2015
Q4 | $15.9M | Buy |
206,223
+29,417
| +17% | +$2.21M | 4.36% | 6 |
|
|
2015
Q3 | $11.8M | Sell |
176,806
-40,669
| -19% | -$3M | 2.91% | 15 |
|
|
2015
Q2 | $16.1M | Sell |
217,475
-3,005
| -1% | -$230K | 2.89% | 14 |
|
|
2015
Q1 | $17.2M | Sell |
220,480
-1,445
| -0.7% | -$110K | 3.11% | 13 |
|
|
2014
Q4 | $16M | Buy |
221,925
+1,715
| +0.8% | +$119K | 3.26% | 14 |
|
|
2014
Q3 | $13.6M | Buy |
220,210
+6,060
| +3% | +$385K | 2.55% | 20 |
|
|
2014
Q2 | $13.7M | Buy |
+214,150
| New | +$13M | 2.28% | 24 |
|
Other funds holding MDT
JCIC Asset Management's MDT Position: Q2 2026 in Review
JCIC Asset Management held its Medtronic (MDT) position steady in Q2 2026 at 235 shares worth $20.4K. The position accounts for 0.01% of the portfolio, ranked #98.
JCIC Asset Management first reported a position in MDT in Q2 2014 and has held it in 46 quarters since. The position peaked at $17.2M in Q1 2015. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- JCIC Asset Management held 235 shares of Medtronic worth $20.4K as of Q2 2026.
- JCIC Asset Management left its Medtronic share count unchanged in Q2 2026.
- Medtronic made up 0.01% of JCIC Asset Management's portfolio in Q2 2026, its #98 holding.
- JCIC Asset Management first reported a position in Medtronic in Q2 2014 and has held it in 46 quarters since.
- JCIC Asset Management's Medtronic position peaked at $17.2M in Q1 2015.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on JCIC Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.